REPORT HIGHLIGHT
4D Bio printing Market size was valued at USD 600.1 million in 2022, expanding at a CAGR of 38.6% from 2023 to 2030.
A tangible object is manufactured using a blueprint in 4D printing, an improved form of 3D printing. When exposed to a predetermined stimulus or energy, such as heat, pressure, ultraviolet radiation, or other energy sources in 4D printing, the produced 3D item, however, changes into diverse shapes and sizes. Special printing materials that turn into itself when exposed to an external energy source are needed for this by 4D printers.
4D Bio printing Market- Market Dynamics
Numerous players are actively adopting and creating 4D bioprinters and smart biomaterials as a result of the ongoing improvements in the 4D biofabrication technology. It is important to note that academics and business leaders are paying close attention to 4D bioprinting. In fact, the amount of related scientific literature has grown at a rate of about 130% over the previous five years, indicating the rising acceptance of 4D bioprinting. A number of start-ups have also appeared in this field as a result of the large range of 4D bioprinting applications, including tissue engineering, regenerative medicine, and drug-related applications.
4D Bio printing Market- Segmentation Analysis:
The Global 4D Bio printing Market is segmented based on technology, application, end-user, and Region.
Based on the application, the biomedical segment is expected to dominate the market during the forecast period. This is due to, individualized implants for patients, and research models. The sector with the most shareholders is the medical and research section, which includes both hospitals and research labs. The model created in research and medical laboratories can be tailored based on the pathology of the patient, which cuts down on both time and expense. In the future years, 4D printers will be able to produce sophisticated medical devices that will revolutionize both the medical industry and the 4D printing business as a whole.
4D Bio printing Market- Geographical Insights
During the projected period, the North American region will dominate the worldwide 4D bio printing market. The main drivers of the market growth are the increased demand for organ transplants and the expansion of technical innovation in the area.
Another region predicted to follow the market trend in North America over the projection period is Asia-Pacific. Technology development and the government's increasing investment in new products are driving the market for 4D printing start-ups to provide enormous prospects.
4D Bio printing Market- Recent Development:
In July 2020, In order to create cutting-edge 4D bio printing technology, DRADS Capital announced its investment in Rokit healthcare.
Key features of the study:
- This proposed research study on the 4D Bio printing Market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
- The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for 4D Bio printing Market
- The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the 4D Bio printing Market
- Impact of COVID-19 on 4D Bio printing Market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on 4D Bio printing Market post-COVID will also be covered.
- In order to give the users of this report a comprehensive view on the 4D Bio printing Market, we have also included competitive landscape and key innovator analysis for the 4D Bio printing Market.
- The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
- The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the 4D Bio printing Market.
- In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
- The global 4D Bio printing Market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL 4D Bio printing Market KEY PLAYERS
- Brighter
- CELLINK
- Guangzhou Medical University
- Harvard Medical School
- CURAM
- Production and Validation Center for Advanced Therapies (Creatio)
- DJO® (now part of Envis)
- Duke University
- ETH Zurich
- GKSS Research Center Geesthacht
- BioG3D
- BIH Center for Regenerative Therapies (BCRT)
- First Graphene
- Evoke Medical
- Ferentis
- Grolltex
GLOBAL 4D Bio printing Market, BY TECHNOLOGY
- Extrusion-based Technology
- Laser-based Technology
- Inkjet-based Technology
- Others
GLOBAL 4D Bio printing Market, BY APPLICATION
GLOBAL 4D Bio printing Market, BY END-USER
- Pharmaceutical and Biotechnology Companies
- Academic Research and Development
- Others
GLOBAL 4D Bio printing Market, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA